THEIA™ development, and testing of artificial intelligence-based primary triage of diabetic retinopathy screening images in New Zealand.
Ehsan VaghefiS YangL XieS HillO SchmiedelR MurphyD SquirrellPublished in: Diabetic medicine : a journal of the British Diabetic Association (2020)
THEIA, an artificial intelligence tool to assist in clinical decision-making, tailored to the needs of the New Zealand national diabetic screening programme, delivered high sensitivity for detecting referable retinopathy within the multi-ethnic New Zealand population with diabetes.
Keyphrases
- artificial intelligence
- diabetic retinopathy
- deep learning
- machine learning
- big data
- optical coherence tomography
- type diabetes
- decision making
- emergency department
- convolutional neural network
- cardiovascular disease
- glycemic control
- quality improvement
- study protocol
- smoking cessation
- randomized controlled trial
- wound healing
- clinical trial
- skeletal muscle
- metabolic syndrome
- insulin resistance
- weight loss